Allegations of Deceptive Marketing and Profit Prioritization Beyond inadequate warnings, plaintiffs allege Novo Nordisk engaged in deceptive marketing practices that created unrealistic expectations while downplaying serious risks
Personalized medicine: Given the individual variability in response to GLP-1 agonists, personalized treatment plans are becoming increasingly important
On the other hand, the good news is that the most critical kinds of preparation for offering GLP-1 specialized nutritional counseling arent really that specialized at all
Ideal Protein is the perfect complement to support your journey for long-term success
[1] [9] If accidental freezing occurs, discard the pen immediately
If the FDA finalizes its April 30, 2026 proposal to exclude semaglutide and tirzepatide from the 503B Bulks List, large-scale 503B compounding of those medications would no longer be legally permissible